| High-Dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma and ... - Cancer Network |
|
|
Cancer Network There are many patients with either renal cell cancer or melanoma who were treated with high-dose IL-2 and who are still alive, having had durable complete responses that are ongoing and that have lasted for decades. The two randomized trials comparing |